Biological variability of glycated hemoglobin

Clinica Chimica Acta

Volumn 411, Issue 21-22, 2010, Pages 1606-1610

  Braga, Federica ^a,b   Dolci, Alberto ^b   Mosca, Andrea ^a   Panteghini, Mauro ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Biological variability; Diabetes mellitus; Glycated hemoglobin

Indexed keywords

HEMOGLOBIN A1C;

AFFINITY CHROMATOGRAPHY; ANALYTIC METHOD; DIABETES MELLITUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION EXCHANGE CHROMATOGRAPHY; PRIORITY JOURNAL; REVIEW; SAMPLING; SYSTEMATIC REVIEW;

DIABETES MELLITUS; EPIDEMIOLOGIC RESEARCH DESIGN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 77956455682     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.07.030     Document Type: Review

References (30)

1. American Diabetes Association Standards of medical care in diabetes-2010. Diab Care 2010, 33(suppl 1):S11-S61.
2. 1c with cardiovascular disease and mortality in adults: the European Prospective Investigation into Cancer in Norfolk. Ann Intern Med 2004, 141:413-420.
3. Selvin E., Steffes M., Zhu H., Matsushita K., Wagenknecht L., Pankow J., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010, 362:800-811.
4. 1c: analysis and standardisation. Clin Chem Lab Med 2003, 41:1199-1212.
5. Little R.R., Rohlfing C.L., Wiedmeyer H.M., Myers G.L., Sacks D.B. NGSP Steering Committee. The National Glycohemoglobin Standardization Program: a five-year progress report. Clin Chem 2001, 47:1985-1992.
6. 1c standardization: history, science and politics. Clin Biochem Rev 2007, 28:163-168.
7. 1c/glycohemoglobin determinations. J Int Fed Clin Chem 1996, 9:62-67.
8. Mosca A., Goodall I., Hoshino T., Jeppsson J., John W., Little R., et al. Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group. Clin Chem Lab Med 2007, 45:1077-1080.
9. 1c. Clin Chem Lab Med 2007, 45:1081-1082.
10. 1c results traceable to the IFCC reference system: the way forward. Clin Chem Lab Med 2007, 45:942-944.
11. Panteghini M. Application of traceability concepts to analytical quality control may reconcile total error with uncertainty of measurement. Clin Chem Med Lab 2010, 48:7-10.
12. Kenny D., Fraser C.G., Petersen P.H., Kallner A. Consensus agreement. Scand J Clin Lab Invest 1999, 59:585.
13. Fraser C.G., Petersen P.H., Libeer J.C., Ricos C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997, 34:8-12.
14. Fraser C.G., Petersen P.H. Analytical performance characteristics should be judged against objective quality specifications. Clin Chem 1999, 45:321-323.
15. Fraser C.G., Harris E.K. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989, 27:409-437.
16. Godsland I.F. Intra-individual variation: significant changes in parameters of lipid and carbohydrate metabolism in the individual and intra-individual variation in different test populations. Ann Clin Biochem 1985, 22:618-624.
17. Howey J.E.A., Bennet W.M., Browning M.C.K., Jung R., Fraser C. Clinical utility of assays of glycosylated haemoglobin and serum fructosamine compared: use of data on biological variation. Diabet Med 1989, 6:793-796.
18. Phillipou G., Phillips P.J. Intraindividual variation of glycohemoglobin: implications for interpretation and analytical goals. Clin Chem 1993, 39:2305-2308.
19. Kolatkar N.S., Cembrowski G.S., Callahan P.L., Etzwiler D. Intensive diabetes management requires very precise testing of glycohemoglobin. Clin Chem 1994, 40:1608-1610.
20. Kilpatrick E.S., Maylor P.W., Keevil B.G. Biological variation of glycated haemoglobin. Implications for diabetes screening and monitoring. Diab Care 1998, 21:261-264.
21. 1c, IgA, prolactin, and free testosterone in healthy women. Clin Chem 2000, 46:551-559.
22. 1c in patients with type 2 diabetes mellitus. Clin Chem Lab Med 2000, 38:1283-1287.
23. Rohlfing C., Wiedmeyer H.M., Little R., Grotz V., Tennill A., England J., et al. Biological variation of glycohemoglobin. Clin Chem 2002, 48:1116-1118.
24. Desmeules P., Cousineau J., Allard P. Biological variation of glycated haemoglobin in a paediatric population and its application to calculation of significant change between results. Ann Clin Biochem 2010, 47:35-38.
25. Pagani F., Panteghini M. Significance of various parameters derived from biological variability for lipid and lipoprotein analyses. Clin Biochem 1993, 26:415-420.
26. 1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004, 50:166-174.
27. 1c and the designated comparison methods in the United States, Japan, and Sweden. Clin Chem 2008, 54:1379-1385.
28. 1c routine assays according to the new IFCC reference method. Clin Lab 2003, 49:657-661.
29. Ricós C., Iglesias N., Garcìa-Lario J.V., Simón M., Cava F., Hernández A., et al. Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem 2007, 44:343-352.
30. MacDonald M.J., Liston L., Carlson I. Seasonality in glycosylated hemoglobin in normal subjects. Does seasonal incidence in insulin-dependent diabetes suggest specific etiology?. Diabetes 1987, 36:265-268.